Connect your AI

Organogenesis Holdings Inc. ORGO Earnings yield

Earnings yield at other companies

IAR

Integra LifeSciencesIART

-67.5%—

MiMedx GroupMDXG

5.2%+1.6pp

Orthofix Medical Inc.OFIX

-13%-3.9pp

BioventusBVS

4.6%+3.0pp

ArtivionAORT

0.7%+0.4pp

AxogenAXGN

-1.8%+61.8pp

Other financials

Income statement

Revenue$37.2M-57.1%

Gross profit$63.0M-22.5%

Operating income-$68.9M-158%

Net income-$53.2M-182%

EPS (diluted)-$0.44-159%

Balance sheet

Cash & equivalents$91.4M-16.9%

Total debt$39.4M+24.8%

Total equity$244.6M+0.7%

Total assets$520.0M+11.3%

Cash flow

Operating cash flow$21.1M+206%

CapEx$3.1M-13.2%

Free cash flow$18.0M+176%

Valuation

Market cap$312.68M-23.7%

Enterprise value$260.72M-21.3%

P/E115×—

P/S0.6×-0.3×

Profitability

Gross margin75.9%+0.8pp

Operating margin0.5%—

Net margin0.5%+0.3pp

FCF margin6.9%—

Returns & leverage

Return on equity1.1%+0.6pp

Debt / equity0.2×0.0×

Current ratio3.5×-0.6×

Where this comes from

Calculated from Organogenesis Holdings Inc.’s reported figures.

net income/market cap=0.9%

Based on trailing twelve months.

The official record: Organogenesis Holdings Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Organogenesis Holdings Inc.'s earnings yield.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Organogenesis Holdings Inc.'s earnings yield?: Organogenesis Holdings Inc. (ORGO) reported earnings yield of 0.9% in Q1 2026.
How has Organogenesis Holdings Inc.'s earnings yield changed year-over-year?: Organogenesis Holdings Inc.'s earnings yield increased by 130.8% year-over-year, from -2.9% to 0.9%.
What is the long-term trend for Organogenesis Holdings Inc.'s earnings yield?: Over 4 years (2020 to 2025), Organogenesis Holdings Inc.'s earnings yield has grown at a 32.5% compound annual growth rate (CAGR), from 1.8% to 5.6%.
What does earnings yield mean?: Trailing-twelve-month net income divided by market capitalization at the quarter end — the inverse of the P/E ratio, expressed as a percentage.